Associated Papers
Persistence of HIV-1 variants with multiple protease inhibitor (PI)-resistance mutations in the absence of PI therapy can be explained by compensatory fixation.
van Maarseveen NM et al.
The Journal of Infectious Diseases, 2007
Genetic evolution of HIV in patients remaining on a stable HAART regimen despite insufficient viral suppression.
Kristiansen TB et al.
Scandinavian Journal of Infectious Diseases, 2005
Human immunodeficiency virus type 1 protease genotype predicts immune and viral responses to combination therapy with protease inhibitors (PIs) in PI-naive patients.
Perez EE et al.
The Journal of Infectious Diseases, 2001
Transmission of antiretroviral-drug-resistant HIV-1 variants.
Yerly S et al.
Lancet (london, England), 1999
Characterization of a human immunodeficiency virus type 1 variant with reduced sensitivity to an aminodiol protease inhibitor.
Patick AK et al.
Journal of Virology, 1995
Select a paper to view details